Clinical trials: Anxiety, Generalized
Generalised Anxiety Disorder
Self-help Lifestyle Medicine for Generalized Anxiety Symptoms
This study will examine the effects of smartphone-based lifestyle medicine for alleviating generalised anxiety symptoms in Chinese population.
- Trial name
- NCT05278455
- Testing
- Lifestyle Medicine
- Where
- Hong Kong
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Chinese University of Hong Kong
Emergency Surgical Procedures, Postoperative Pain
Postoperative Progressive Relaxation Exercises for Pain and Anxiety After Emergency Surgery
This randomized controlled trial investigated the effectiveness of postoperative progressive relaxation exercises (PRE) on pain, anxiety, and physiological parameters among adult patients undergoing emergency general surgery.
- Conditions
- Emergency Surgical Procedures, Postoperative Pain, Postoperative Anxiety
- Trial name
- PRE-ES (NCT07301073)
- Testing
- Progressive Relaxation Exercises (PRE)
- Where
- Turkey (Türkiye)
- Volunteers
- 70 people
- Sponsor
- Agri Ibrahim Cecen University
Social Anxiety Disorder
Efficacy of Quetiapine in Generalised Social Anxiety Disorder
This trial will explore the efficacy of quetiapine in Social Anxiety Disorder, generalized type. The following elements of response will be tested: number of responders to treatment, time to response, effect size as measured with…
- Trial name
- NCT00302770
- Testing
- quetiapine
- Where
- Netherlands
- Volunteers
- 50 people
- Sponsor
- AstraZeneca
Mental Health and General Well-being
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
This study is testing whether a short, daily, app-based meditation can help young adults feel better in their everyday lives. Adults aged 18-40 years who live in the United States and have not meditated regularly (defined as more…
- Trial name
- BEGIN II (NCT07607782)
- Testing
- Miracle of Mind meditation, Neutral audio learning task
- Volunteers
- 354 people, healthy volunteers welcome
- Sponsor
- Beth Israel Deaconess Medical Center
Generalized Anxiety Disorder
POC Study in Partially Responsive Generalized Anxiety Disorder
This study aims to evaluate whether PF-06372865 is safe and effective in the treatment of sub-optimally controlled symptoms of generalized anxiety disorder during two 4-week treatment periods using a Sequential Parallel…
- Trial name
- NCT02310568
- Testing
- PF-06372865.
- Where
- 47 sites in United States
- Volunteers
- 90 people
- Sponsor
- Pfizer
Major Depressive Episode (MDE), Major Depressive Disorder (MDD)
LHC-CIDI-5 in Hong Kong
The World Health Organization Composite International Diagnostic Interview-5th (CIDI-5) is a standardized diagnostic tool used to assess the prevalence of mental and substance use disorders over varying time frames (30 days, 12…
- Conditions
- Major Depressive Episode (MDE), Major Depressive Disorder (MDD), Persistent Depressive Disorder (PDD), Suicidal Ideation
- Trial name
- NCT06804525
- Testing
- CIDI-5, LHC-CIDI-5
- Where
- Hong Kong
- Volunteers
- 2,500 people
- Sponsor
- The University of Hong Kong
Anxiety
Therapeutic Communication Training of the Stretcher Bearers on the Patient Anxiety (STRESSCOM)
Anxiety is a form of psychic and/or physical discomfort caused by the feeling of the imminence of a danger. It is a frequent perioperative manifestation of patients.
- Trial name
- STRESSCOM (NCT03849976)
- Testing
- Therapeutic communication
- Where
- France
- Volunteers
- 130 people
- Sponsor
- Lille Catholic University
Anxiety Disorders
A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)
The study will look at the effect of MK0777on reducing anxiety in subjects with general anxiety disorder. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time.
- Trial name
- NCT00543920
- Testing
- MK0777
- Volunteers
- 60 people
- Sponsor
- Merck Sharp & Dohme LLC
Anxiety, Depression
Community Applications of the MindShift App
Despite considerable, replicated evidence of the efficacy and effectiveness of cognitive behavioural therapy, there is an insufficient number of professionals (e.g., psychologists, psychiatrists) in North America to provide…
- Conditions
- Anxiety, Depression, Anxiety Generalized, Anxiety Disorders and Symptoms
- Trial name
- NCT04562948
- Where
- Canada
- Volunteers
- 380 people, healthy volunteers welcome
- Sponsor
- University of Windsor
Alcoholism, Generalized Anxiety Disorder
Levetiracetam for the Treatment of Alcohol Dependence and Anxiety
The purpose of this study is to determine if levetiracetam is effective in treating alcohol dependence in patients with anxiety symptoms.
- Conditions
- Alcoholism, Generalized Anxiety Disorder, Panic Disorder, Social Phobia
- Trial name
- NCT00141115
- Testing
- levetiracetam
- Where
- United States
- Volunteers
- 3 people
- Sponsor
- New York State Psychiatric Institute
Generalized Anxiety Disorder
Echinacea Angustifolia (AnxioCalm) in Anxiety
This study evaluates whether Echinacea angustifolia (AnxioCalm) is a safe and effective treatment for mild to moderate Generalized Anxiety Disorder (GAD) symptoms.
- Trial name
- NCT03463018
- Testing
- Echinacea angustifolia
- Where
- Georgia
- Volunteers
- 100 people
- Sponsor
- EuroPharma, Inc.
Anxiety, Sexual Dysfunction
Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction
Anxious patients are now treated with Selective Serotonin Reuptake Inhibitor medications (common antidepressants) which elevate serotonin and thus alleviate anxiety.
- Trial name
- NCT00174850
- Testing
- Gaitril
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- State University of New York - Upstate Medical University
Generalized Anxiety
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder
The primary objective is to evaluate the efficacy of a 100 mg dose of saredutant compared to placebo in patients with generalized anxiety disorder.
- Trial name
- NCT00417118
- Testing
- Saredutant, Escitalopram
- Where
- 7 sites in Belgium, Canada and 5 more
- Volunteers
- 365 people
- Sponsor
- Sanofi
Generalized Anxiety Disorder
The Effect of Psychoeducation Based on Acceptance and Commitment Therapy Applied to Patients Diagnosed With Generalized Anxiety Disorder on Cognitive Avoidance Levels and Coping Attitudes
This study will be conducted to determine the effects of acceptance and commitment therapy-based psychoeducation on cognitive avoidance levels and coping attitudes in patients diagnosed with generalized anxiety disorder.
- Trial name
- NCT06972563
- Testing
- Psychoeducation Based on Acceptance and Commitment Therapy Applied to Patients Diagnosed with Generalized Anxiety Disorder, The initiative was not implemented.
- Where
- Turkey (Türkiye)
- Volunteers
- 60 people
- Sponsor
- Arzu Çalışkan
Social Phobia
Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP)
SSRI's are considered first-line treatments for GSP, however many patients continue to have significant symptoms despite an adequate trial of an SSRI.
- Trial name
- NCT00182455
- Testing
- Topiramate
- Where
- Canada
- Volunteers
- 12 people
- Sponsor
- McMaster University
Generalized Anxiety, Worry
Training Mental Habits Study
Generalized Anxiety Disorder (GAD) is a chronic condition whose hallmark feature is excessive and uncontrollable worry (American Psychiatric Association, 2013).
- Trial name
- NCT03205332
- Testing
- Concreteness Training
- Where
- Canada
- Volunteers
- 121 people
- Sponsor
- Toronto Metropolitan University
Generalized Anxiety Disorder
Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
This is a randomized double-blind placebo-controlled phase 3 clinical trial to further validate the effectiveness and safety of Shugan Jieyu Capsules in treating generalized anxiety disorder.
- Trial name
- NCT05772104
- Testing
- Shugan Jieyu Capsules
- Where
- China
- Volunteers
- 495 people
- Sponsor
- Sichuan Jishengtang Pharmaceutical Co., Ltd.
Nutrition Knowledge, Generalized Anxiety Disorder (GAD)
Digital Versus Hybrid Interventions in Promoting Nutrition Knowledge Among Saudi Adolescent Girls
This study primarily aims to compare the efficacy of different approaches to nutrition education intervention delivery in improving nutrition knowledge (NK) among Saudi adolescent girls.
- Conditions
- Nutrition Knowledge, Generalized Anxiety Disorder (GAD), Food Habits, Body Mass Index
- Trial name
- NCT06836336
- Testing
- Hybrid therapy, Fully digital
- Where
- Saudi Arabia
- Volunteers
- 104 people, healthy volunteers welcome
- Sponsor
- Umm Al-Qura University
Generalised Anxiety Disorder
Trial of Sertraline Versus Cognitive Behaviour Therapy for Generalised Anxiety
Generalised Anxiety Disorder (GAD) is common, causes unpleasant symptoms and impairs people's functioning. It is often chronic and may be accompanied by depression and other anxiety disorders.
- Trial name
- ToSCA (NCT02347033)
- Testing
- Sertraline, Cognitive Behavioural Therapy
- Where
- United Kingdom
- Volunteers
- 5 people
- Sponsor
- University College, London
Stress, Psychological, Stress, Emotional
Investigation of Stress Levels and Lifestyle of a Sample of Greek General Surgeons in Covid-19
A new pandemic appeared in early 2020, also known as the coronavirus (Covid-19), affecting all health systems worldwide. Medical and nursing staff make every effort to treat patients resulting in physical and psychological…
- Conditions
- Stress, Psychological, Stress, Emotional, Life Style Induced Illness, Anxiety Depression
- Trial name
- NCT04791085
- Where
- Greece
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- National and Kapodistrian University of Athens